Ownership and insider activity for CVS Health Corp. (CVS): recent transactions by executives and directors. Track how corporate insiders are trading the stock.
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home.
Price
| Price | $90.25 (closing price, October 30, 2026) |
| Market Cap | $115.4B |
| Exchange | NYSE |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-06-26 | Clark James David | F-InKind | 454 | $41K |
| 2026-05-31 | Newman Brian | F-InKind | 2,478 | $225K |
| 2026-05-31 | Compton-Phillips Amy | F-InKind | 7,618 | $693K |
| 2026-05-20 | AGUIRRE FERNANDO | D-Return | 30,437 | $2.9M |
| 2026-05-21 | AGUIRRE FERNANDO | D-Return | 1,563 | $146K |
| 2026-05-19 | ROBBINS LARRY | S-Sale | 1,983,387 | $187.3M |
| 2026-05-19 | ROBBINS LARRY | S-Sale | 151 | $14K |
| 2026-05-20 | ROBBINS LARRY | S-Sale | 797,628 | $74.6M |
| 2026-05-20 | ROBBINS LARRY | S-Sale | 152,691 | $14.5M |
| 2026-05-20 | ROBBINS LARRY | S-Sale | 66,881 | $6.4M |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.37B | $1.70B | $4.06B | $5.68B | $7.85B | $9.41B | $12.95B | $8.20B | $8.59B | $8.51B |
| Short-term Investments | $87.0M | $111.0M | $2.52B | $2.37B | $3.00B | $3.12B | $2.78B | $3.26B | $2.41B | $2.15B |
| Receivables | $12.16B | $13.18B | $17.63B | $19.62B | $21.74B | $24.43B | $27.28B | $35.23B | $36.47B | $39.78B |
| Inventory | $14.76B | $15.30B | $16.45B | $17.52B | $18.50B | $17.76B | $19.09B | $18.02B | $18.11B | $19.25B |
| Total Current Assets | $31.04B | $31.23B | $45.24B | $50.30B | $56.37B | $60.01B | $65.63B | $67.86B | $68.64B | $74.71B |
| Property, Plant & Equipment | $10.18B | $10.29B | $11.35B | $32.90B | $33.34B | $32.02B | $30.75B | $30.43B | $28.94B | $28.06B |
| Goodwill | $38.25B | $38.45B | $78.68B | $79.75B | $79.55B | $79.12B | $78.15B | $91.27B | $91.27B | $85.48B |
| Intangible Assets | $13.51B | $13.63B | $36.52B | $33.12B | $31.14B | $29.03B | $24.80B | $29.23B | $27.32B | $25.51B |
| Total Assets | $94.46B | $95.13B | $196.46B | $222.45B | $230.72B | $233.00B | $228.28B | $249.73B | $253.22B | $261.06B |
| Accounts Payable | $7.95B | $8.86B | $8.93B | $10.49B | $11.14B | $12.54B | $14.84B | $14.90B | $15.89B | $59.38B |
| Short-term Debt | $1.92B | $4.82B | $1.99B | $3.78B | $5.44B | $4.21B | $1.78B | $2.97B | $5.74B | $5.80B |
| Total Current Liabilities | $26.25B | $30.65B | $44.01B | $53.30B | $62.02B | $67.81B | $69.42B | $79.19B | $84.61B | $88.69B |
| Long-term Debt | $25.61B | $22.18B | $71.44B | $64.70B | $59.21B | $51.97B | $50.48B | $58.64B | $60.53B | $72.88B |
| Total Liabilities | $57.63B | $57.44B | $137.91B | $158.28B | $161.01B | $157.62B | $156.51B | $173.09B | $177.49B | $185.68B |
| Retained Earnings | $38.98B | $43.56B | $40.91B | $45.11B | $49.64B | $54.91B | $56.40B | $61.60B | $62.84B | $61.20B |
| Total Equity | $36.83B | $37.69B | $58.23B | $63.86B | $69.39B | $75.08B | $71.47B | $76.46B | $75.56B | $75.21B |
| Total Debt | $27.53B | $27.00B | $73.43B | $89.00B | $85.04B | $76.00B | $70.73B | $79.39B | $82.92B | $93.59B |
| Net Debt | $24.07B | $25.20B | $66.85B | $80.95B | $74.19B | $63.47B | $55.01B | $67.93B | $71.93B | $82.94B |
| Working Capital | $4.79B | $581.0M | $1.23B | -$3.00B | -$5.65B | -$7.80B | -$3.79B | -$11.33B | -$15.96B | -$13.98B |
Financial Health
| Debt / Equity | 0.96 |
| Current Ratio | 0.87 |
| Piotroski F-Score | 5 |
| Altman Z-Score | 2.26 |
Profitability
| Return on Equity | 6.43% |
| Return on Invested Capital | 4.09% |
| Return on Assets | 1.93% |
| Gross Margin | 14.15% |
| Operating Margin | 2.00% |
| Net Margin | 1.18% |
Related companies: UNH · CI · ELV · HUM · CNC · MOH · OSCR
Explore sector: Healthcare · Medical - Healthcare Plans
More sections of CVS: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks